Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

about

Difference in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases.

P2860

Q46541574-511A3C2C-2115-489B-BA72-7B147771E26B

P2860

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q53285173

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@en

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@nl

type

Item

label

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@en

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@nl

prefLabel

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@en

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@nl

P1476

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

@en

P2093

Ashwin N Ananthakrishnan

http://www.w3.org/2001/XMLSchema#string

Elizabeth Andrews

http://www.w3.org/2001/XMLSchema#string

Grace Conway

http://www.w3.org/2001/XMLSchema#string

John J Garber

http://www.w3.org/2001/XMLSchema#string

Vijay Yajnik

http://www.w3.org/2001/XMLSchema#string

William Tan

http://www.w3.org/2001/XMLSchema#string

P2860

How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?

Self-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical care

Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.

Who should operate on patients with ovarian cancer? An evidence-based review.

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.

Approaches to improve quality of care in inflammatory bowel diseases.

Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review.

Economic evaluations on centralisation of specialised healthcare services: a systematic review of methods.

P304

1234-1239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001133

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nienke Z Borren

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28520589

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

5531761

http://www.w3.org/2001/XMLSchema#string

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

about

P2860

P2860

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932